Target intelligence / Profile preview

Snake venom component

Molecular classification
Enzyme (e.g., snake venom serine protease, snake venom metalloproteinase, phospholipase A2), Toxin (e.g., neurotoxin, cytotoxin, cardiotoxin), Other (C-type lectin-like protein, disintegrin, low molecular weight peptide)
01

Overview

Snake venom components encompass a vast array of chemically and functionally distinct molecules, primarily proteins and peptides, secreted by specialized glands in venomous snakes[1][3][2]. These molecules modulate critical biological processes such as coagulation, neurotransmission, and cell integrity, and are responsible for both the deadly effects and promising therapeutic applications of venom. The main classes include enzymes (serine proteases, metalloproteinases, phospholipases), toxins (neurotoxins, cytotoxins, cardiotoxins), disintegrins, and other low molecular weight peptides, each with specialized targets in animal physiology[1][2][3][6]. Some components have been exploited for drug development (e.g., ACE inhibitors, integrin antagonists), while antivenoms serve as lifesaving interventions for envenomation. The extreme diversity and synergistic actions of these molecules pose major challenges for therapeutic development and clinical safety[1][2][3][6].

Other names
snake venom proteinssnake venom toxinssnake venom enzymessnake toxins
02

Mechanism of action

Enzymatic hydrolysis (proteolytic cleavage of blood proteins, phospholipids, etc.)\nIrreversible binding/blockade of receptors (e.g., neurotoxins bind acetylcholine receptors at the neuromuscular junction)\nDisruption of cell membranes (phospholipases, cytotoxins)\nModulation of signaling pathways (interference with integrins, kinins, complement)

03

Biological functions

Hemostasis modulation (blood coagulation, anticoagulation, fibrinolysis)Neuromuscular interference (paralysis, neurotransmission blockade)Tissue damage (necrosis, hemorrhage, cell membrane lysis)Inflammatory response inductionImmune modulation/interferenceCell proliferation (some show anti-angiogenic or anti-tumor properties)Digestion of prey (hydrolytic enzymes)
04

Disease associations

Hemostatic disorders (bleeding, thrombosis, coagulopathy)Tissue destruction (necrosis, hemorrhage)Neurodegenerative symptoms (paralysis following neurotoxin exposure)Infection (antimicrobial peptides)Cancer (some components have antitumor activity)InflammationCardiovascular disease (effects on blood pressure and vascular integrity)
05

Safety considerations

High toxicity (rapid onset neurological, vascular, and tissue destruction effects)Species and individual variability in venom composition complicates therapyDifficulties in targeted drug delivery (biological instability of peptide/protein drugs)Allergic reactions and serum sickness following antivenom administrationRisk of off-target effects due to broad-spectrum enzyme and toxin actions
06

Interacting drugs

Antivenoms (polyvalent, species-specific serum therapies targeting the broad spectrum of venom components)

3 more in the full profile.

07

Biomarkers

Enzyme-specific activity (e.g., elevated phospholipase A2 activity, metalloproteinase or serine protease markers)Changes in blood coagulation profiles (D-dimer, fibrinogen fragmentation)Specific circulating toxins following envenomation

Beyond the preview

Go deeper on Snake venom component.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Snake venom component.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call